Clinical & translational oncology

• 

  Año 2017, Vol. 19, Número 1 (January 2017)

  • Review Article

    • Safety and efficacy of primary thromboprophylaxis in cancer patients

      Ignacio García Escobar, Maite Antonio, Silvia García Adrián, Analia Rodríguez Garzotto, Andrés Jesús Muñoz Martín, Sociedad Española de Oncología Médica

      • Resumen

      págs. 1-11

      

    • Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma

      P. Jiménez Fonseca, José Manuel Gómez Sáez, Francisco Javier Santamaría Sandi, Jaume Capdevila Castillon, Elena Navarro González, Carles Zafón Llopis, Teresa Ramón y Cajal, Garcilaso Riesco Eizaguirre, Enrique Grande Pulido, Juan Carlos Galofré Ferrater

      • Resumen

      págs. 12-20

      

    • Targeted cancer therapy: interactions with other medicines

      David Conde Estévez

      • Resumen

      págs. 21-30

      

    • Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

      Felipe Couñago Lorenzo, Aurora Rodríguez Pérez, Patricia Calvo Crespo, Javier Luna Tirado, José Luis Monroy Antón, Begoña Taboada Valladares, V. Díaz Díaz, Núria Rodríguez de Dios

      • Resumen

      págs. 31-43

      

    • Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments

      P. Zarzosa, N. Navarro, I. Giralt, C. Molist, Ana Almazán Moga, I. Vidal, Aroa Soriano Fernández, M. F. Segura, R. Hladun, Alberto Villanueva Garatachea, Soledad Gallego Melcón, J. Roma

      • Resumen

      págs. 44-50

      

  • Research Article

    • Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab

      A. Hilario Barrio, Juan Manuel Sepúlveda Sánchez, A. Hernández Laín, E. Salvador Álvarez, L. Koren Fernández, R. Manneh, Y. Ruano, A. Pérez Núñez, Alfonso Lagares, Ana Ramos González

      • Resumen

      págs. 51-57

      

    • Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma

      T. Kauttu, H. Mustonen, S. Vainionpää, L. Krogerus, I. I. K. Ilonen, J. V. Räsänen, J. A. Salo, P. Puolakkainen

      • Resumen

      págs. 58-66

      

    • Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer

      P. Franco, R. Ragona, F. Arcadipane, M. Mistrangelo, Paola Cassoni, N. Rondi, M. Morino, P. Racca, U. Ricardi

      • Resumen

      págs. 67-75

      

    • Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

      A. Di Cataldo, A. Agodi, Julia Balaguer Guill, A. Garaventa, M. Barchitta, Vanessa Segura, M. Bianchi, Victoria Castel Sánchez, A. Castellano, S. Cesaro, José Miguel Couselo Sánchez, Ofelia Cruz Martínez, P. D Angelo, B. De Bernardi, Joaquín Donat Colomer, Nagore García de Andoin Barandiaran, M. I. Hernandez, M. La Spina, M. Lillo Lillo, Ricardo López Almaraz, R. Luksch, S. Mastrangelo, M. E. Mateos González, Javier Molina Garicano, C. Moscheo, R. Mura, F. Porta, G. Russo, A. Tondo, M. Torrent, S. Vetrella, J. A. Villegas, E. Viscardi, G. A. Zanazzo, María Adela Cañete Nieto

      • Resumen

      págs. 76-83

      

    • Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients

      J.-Y. Chen, X. Wu, C.-Q. Hong, J. Chen, X.-L. Wei, L. Zhou, H.-X. Zhang, Y.-T. Huang, L. Peng

      • Resumen

      págs. 84-90

      

    • Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study

      Joaquín Gavilá Gregori, Miguel Ángel Seguí Palmer, Lourdes Calvo Martínez, T. López Fernández, Joaquín Jesús Alonso Martín, Mónica Farto Paredes, Rainel Sánchez de la Rosa

      • Resumen

      págs. 91-104

      

    • CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary?

      David Calvo Temprano, Emilio Esteban González, P. Jiménez Fonseca, Belinda Fernández

      • Resumen

      págs. 105-110

      

    • Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification

      Francisco Pena Pardo, Ana María García Vicente, Mariano Amo Salas, Jesús López Fidalgo, José Antonio Garrido Robles, J. A. de Ayala Fernández, Pablo del Saz Saucedo, Mercedes Muñoz Pasadas, Angel Soriano Castrejón

      • Resumen

      págs. 111-116

      

    • Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma

      F. Aya, Aranzazu Fernandez Martinez, Lydia Gaba, Iván Victoria, M. Tosca, Estela Pineda, Pedro Gascón Vilaplana, Aleix Prat, Ana Arance Fernández

      • Resumen

      págs. 119-124

      

    • Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature

      Ricardo Bonfim-Silva, L. E. B. Souza, F. U. F. Melo, V. C. Oliveira, D. A. R. Magalhães, H. F. Oliveira, D. T. Covas, Aparecida Maria Fontes

      • Resumen

      págs. 125-133